RecruitingNot ApplicableNCT07206602

AI-Guided Left Bundle Branch Area Pacing

A Pilot Study Assessing Outcomes Of Artificial Intelligence-Guided Left Bundle Branch Area Pacing For Cardiac Resynchronization In Heart Failure


Sponsor

Mayo Clinic

Enrollment

224 participants

Start Date

Jan 23, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and clinical outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Age: 18 years or older.
  • Left Ventricular Ejection Fraction (LVEF): \<50% within 6 months prior to enrollment.
  • QRS Duration: Resting QRS duration ≥ 130 ms on ECG OR anticipated right ventricular pacing \> 40% OR device in place with right ventricular pacing \> 40% within 6 months prior to enrollment.
  • Medical Therapy: Optimized on guideline-directed medical therapy for heart failure.
  • AI-ECG probability of low LVEF: \>0.5

Exclusion Criteria3

  • Age less than 18 years old
  • Inability to follow-up
  • Pregnancy

Interventions

DEVICEAI-assisted Left Bundle Branch Area Pacing

Patients will undergo a Left Bundle Branch Area Pacing (LBBAP) procedure using AI assisted technology

PROCEDURELeft Bundle Branch Area Pacing

Patients will undergo a Left Bundle Branch Area Pacing (LBBAP) procedure


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07206602


Related Trials